Abbott Laboratories faced with anti-Aids drug dilemma

The Latin American emerging economy served notice last month it would use powers under global trade rules to break Abbott's patent and make a generic copy of the Kaletra pill to cut the costs of its fight against the disease.

Abbott issued a vitriolic response last week, accusing Brazilian politicians of putting "short-term manoeuvring" over the interests of its own people.

It has to decide within 10 days of the request whether to cut its prices or lose its business to a Brazilian manufacturer that will make them for half the $1.17 Abbott charges. The deadline is understood to fall on Wednesday.

The spat is a test case that will have huge implications for both the global fight against HIV/Aids and the biotech industry in the UK, US and Europe.

It would be the first time a country has invoked its rights under concessions won during World Trade Organisation negotiations that allows governments to make cheap copies of drugs needed to tackle local health emergencies.

The Brazilian government says that as many as 600,000 Brazilians carry the virus and forecasts that by 2008 it will be spending $520m (£290m) a year on a cocktail of drugs including Kaletra.

"Brazil is concerned about doing a good job of treating those Brazilians who need it, with the proper medication," said Humberto Costa, the country's health minister.

Health and poverty groups fully support Brazil's action. Jim Kim, director of the department of HIV/Aids at the World Health Organisation in Geneva, said: "The Brazilian government is perfectly within its rights to suspend the patent of Kaletra ... so as to develop it at more accessible prices."

Oxfam said buying Aids drugs from Abbott and its fellow US giants Merck and Gilead Sciences used up 67 per cent of the country's budget for tackling the disease.

In its statement, Abbott said that as the world's ninth-largest economy, Brazil's demand for the same rights as the poorest countries was "against the spirit" of the agreement. It said: "Such a mis-step puts short-term manoeuvring ahead of the access to new and improved treatments."

It said compulsory licensing would have "significant negative consequences" for the development of future treatments for a range of diseases.

Sport
Floyd Mayweather will relinquish his five world titles after beating Manny Pacquiao
boxing
Arts and Entertainment
tvGame of Thrones season 5 ep 4, review - WARNING: contains major spoiliers!
News
Tottenham legend Jimmy Greaves has defended fans use of the word 'Yid'
people
Life and Style
tech
Arts and Entertainment
The Ridiculous Six has been produced by Adam Sandler, who also stars in it
filmNew controversy after nine Native American actors walked off set
Life and Style
Google celebrates Bartolomeo Cristofori's 360th birthday
techGoogle Doodle to the rescue
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

Day In a Page

Fishing for votes with Nigel Farage: The Ukip leader shows how he can work an audience as he casts his line to the disaffected of Grimsby

Fishing is on Nigel Farage's mind

Ukip leader casts a line to the disaffected
Who is bombing whom in the Middle East? It's amazing they don't all hit each other

Who is bombing whom in the Middle East?

Robert Fisk untangles the countries and factions
China's influence on fashion: At the top of the game both creatively and commercially

China's influence on fashion

At the top of the game both creatively and commercially
Lord O’Donnell: Former cabinet secretary on the election and life away from the levers of power

The man known as GOD has a reputation for getting the job done

Lord O'Donnell's three principles of rule
Rainbow shades: It's all bright on the night

Rainbow shades

It's all bright on the night
'It was first time I had ever tasted chocolate. I kept a piece, and when Amsterdam was liberated, I gave it to the first Allied soldier I saw'

Bread from heaven

Dutch survivors thank RAF for World War II drop that saved millions
Britain will be 'run for the wealthy and powerful' if Tories retain power - Labour

How 'the Axe' helped Labour

UK will be 'run for the wealthy and powerful' if Tories retain power
Rare and exclusive video shows the horrific price paid by activists for challenging the rule of jihadist extremists in Syria

The price to be paid for challenging the rule of extremists

A revolution now 'consuming its own children'
Welcome to the world of Megagames

Welcome to the world of Megagames

300 players take part in Watch the Skies! board game in London
'Nymphomaniac' actress reveals what it was really like to star in one of the most explicit films ever

Charlotte Gainsbourg on 'Nymphomaniac'

Starring in one of the most explicit films ever
Robert Fisk in Abu Dhabi: The Emirates' out-of-sight migrant workers helping to build the dream projects of its rulers

Robert Fisk in Abu Dhabi

The Emirates' out-of-sight migrant workers helping to build the dream projects of its rulers
Vince Cable interview: Charging fees for employment tribunals was 'a very bad move'

Vince Cable exclusive interview

Charging fees for employment tribunals was 'a very bad move'
Iwan Rheon interview: Game of Thrones star returns to his Welsh roots to record debut album

Iwan Rheon is returning to his Welsh roots

Rheon is best known for his role as the Bastard of Bolton. It's gruelling playing a sadistic torturer, he tells Craig McLean, but it hasn't stopped him recording an album of Welsh psychedelia
Russell Brand's interview with Ed Miliband has got everyone talking about The Trews

Everyone is talking about The Trews

Russell Brand's 'true news' videos attract millions of viewers. But today's 'Milibrand' interview introduced his resolutely amateurish style to a whole new crowd
Morne Hardenberg interview: Cameraman for BBC's upcoming show Shark on filming the ocean's most dangerous predator

It's time for my close-up

Meet the man who films great whites for a living